Stents Market Forecasts to 2028 – Global Analysis By Type (Balloon-Expandable Stents and Self-Expandable Stents), Material(Metallic Biomaterials, Natural Biomaterials and Others), Product, End User and By Geography
According to Stratistics MRC, the Global Stents Market is accounted for $11,649.12 million in 2020 and is expected to reach $20,316.62 million by 2028 growing at a CAGR of 7.2% during the forecast period. Increasing number of patient pool with chronic disease, rapid technological advancements and growing number of coronary artery diseases are driving the market growth. However, high costs of stent implants treatment are hampering the growth of the market.
A stent is a short mesh tube acting as a scaffold in order to keep the artery open. It restores blood or other fluids, depending on where it is placed. Stent implants are most commonly employed to treat heart abnormalities such as blocked blood vessels. They are also employed in the ureter in order to prevent obstruction of urine from the kidney, in the gall bladder to allow passage of bile in patients, in the abdomen & gastrointestinal tract among others.
Based on the type, the balloon-expandable stents segment is going to have lucrative growth during the forecast period as they support high radial outward force owing to their long-term integrity, rigidity and higher elasticity. Focus of various market players to develop innovative products also contribute to the market growth. By geography, North America is going to have high growth during the forecast period due to the rise in incidences of cardiovascular diseases coupled with increasing geriatric population in the region.
Some of the key players profiled in the Stents Market include Abbott Laboratories, B. Braun, Melsungen AG, Biotronik SE & Co. KG, Boston Scientific Corporation, C.R. Bard, Inc., Elixir Medical Corporation, Medtronic plc, Microport Scientific Corporation, STENTYS S.A. and Terumo Corporation.
Estimated Market Size in 2020:
USD 11,649.12 million
Compound Annual Growth Rate (CAGR) from 2020 to 2028:
Predicted 2028 Value:
USD 20,316.62 million
Tables, Graphs & Figures
Type, Material, Product, End User and Region
Core Drivers and Opportunities:
Restraining Factors & Market Threats:
• Balloon-Expandable Stents
• Self-Expandable Stents
• Metallic Biomaterials
• Natural Biomaterials
• Polymers Biomaterials
• Biliary Stents
• Coronary Stents
• Neurovascular Stents
• Peripheral Stents
• Stent-Related Implants
• Non-Vascular Stents
End Users Covered:
• Ambulatory Surgical Centers
• North America
o Rest of Europe
• Asia Pacific
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2018, 2019, 2020, 2024 and 2027
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Key Questions Answered In The Report
The Global Stents Market is majorly driven by increasing number of patient pool with chronic disease, rapid technological advancements and growing number of coronary artery diseases.
The coronary stents segment is growing at a highest CAGR owing to increase in prevalence of cardiovascular diseases along with the rising geriatric population.
North America dominated with a significant market share due to the factors such as sedentary lifestyles in the region and increasing number of cardiovascular diseases.
Asia Pacific market is growing at a highest CAGR owing to the large aging population, improving healthcare infrastructure and growing health awareness in the region.
Key players in Stents Market include Abbott Laboratories, B. Braun, Melsungen AG, Biotronik SE & Co. KG, Boston Scientific Corporation, C.R. Bard, Inc., Elixir Medical Corporation, Medtronic plc, Microport Scientific Corporation, STENTYS S.A. and Terumo Corporation.
Select License Type
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.